News

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Accord Healthcare’s Henlius-partnered Hetronifly ...
Gilead Sciences and Kymera Therapeutics have entered into a partnership worth as much as $750m to develop a molecular glue ...
The Committee for Medicinal Products for Human Use (CHMP) has recommended that the drug be authorised to treat unresectable ...
The Considered has announced the appointment of Emily Knight-Kristoffersen as its new chief creative officer.
This is the key thing you need to know about healthcare professional (HCP) engagement – the desire for authentic human ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that it has become a founding member of a global ...
Johnson & Johnson (J&J) has announced that its CD38-directed antibody Darzalex (daratumumab) has been recommended by the ...
The European Commission (EC) has approved argenx’s Vyvgart (efgartigimod alfa) subcutaneous (SC) injection to treat chronic ...
AstraZeneca (AZ) and Daiichi Sankyo’s Datroway (datopotamab deruxtecan) has been granted accelerated approval by the US Food ...
Jones, PhD, Clinical Strategist (Oncology) and Worldwide Patient Integration Lead to Present at the 2025 Patient Centricity & ...
Medical affairs, situated at the intersection of data and dialogue, is primed to lead this shift. By partnering with ...
Join us at 1.00pm (BST)/2.00pm (CEST)/8.00am (EDT) on Thursday 10th July for an expert-led discussion exploring the latest ...